Stock Movers

• Broadcom Rises on Strong Forecast, Lululemon's CEO Steps Down, Oracle Sinks

  On this episode of Stock Movers: - Broadcom (AVGO) is rising afterhours. The company gave a strong revenue forecast for the current quarter, signaling that demand for AI data center equipment is fueling growth. The company said sales will be about $19.1 billion in the fiscal first quarter, and Chief Executive Officer Hock Tan expects AI semiconductor revenue to double year-over-year to $8.2 billion. - Lululemon (LULU) shares jumped in postmarket trading. The company raised its full-year outlook, and said Chief Executive Officer Calvin McDonald is stepping down as the company looks to reignite growth amid pressure from competition. - Oracle (ORCL) sank 10% today. The company forecast 3Q cloud sales growth below analyst estimates, raising concerns that supply constraints are preventing the cloud infrastructure provider from converting its large backlog to actual revenues.See omnystudio.com/listener for privacy information.

  --------  

  3:44

  --------

  3:44
• Closing Bell: Fertilizer Stocks Jump, Eli Lilly Gains, Lululemon Earnings

  Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Greifeld, Tim Stenovec and Carol Massar. On this episode of Stock Movers: - The Mosaic Company (MOS) is up by 6% at the close. Fertilizer stocks jumped after Ukraine said drones had hit two fertilizer plants in western Russia, on concerns that geopolitical tensions will affect supply chains for key crop nutrients. - Eli Lilly (LLY) finished 1.58% higher. A late-stage study showed that a next-generation obesity shot helped patients lose almost a quarter of their body weight, potentially making the experimental drug the most potent weight-loss medicine yet. - Lululemon (LULU) is spiked as much as 8% afterhours. The company released earnings and boosted its full year EPS guidance. They also announced that CEO Calvin McDonald will step down.See omnystudio.com/listener for privacy information.

  --------  

  7:46

  --------

  7:46
• Eli Lilly Gains on Experimental Shot, Gemini Space Station Rises, Oracle Sinks on 3Q Forecast

  On this episode of Stock Movers: - Eli Lilly (LLY) gains 2.6% as a late-stage study showed that a next-generation obesity shot helped patients lose almost a quarter of their body weight, potentially making the experimental drug the most potent weight-loss medicine yet. - Gemini Space Station (GEMI) rose 20% after its application for a derivatives exchange was approved by the Commodity Futures Trading Commission in a move that will allow the company to join the fast-growing field of prediction markets. - Oracle (ORCL) sank 13% after the company forecast 3Q cloud sales growth below analyst estimates, raising concerns that supply constraints are preventing the cloud infrastructure provider from converting its large backlog to actual revenues.See omnystudio.com/listener for privacy information.

  --------  

  5:39

  --------

  5:39
• Oracle Falls on Disappointing Cloud Sales; Gemini Rallies; Eli Lilly Jumps

  - Shares of Oracle (ORCL) fell in early trading after the company reported a jump in spending on AI data centers and other equipment, rising outlays that are taking longer to translate into cloud revenue than investors want. Fiscal second-quarter cloud sales increased 34% to $7.98 billion, while revenue in the company’s closely watched infrastructure business gained 68% to $4.08 billion. Both numbers fell just short of analysts’ estimates. Known for its database software, Oracle has recently found success in the competitive cloud computing market. It’s engaging in a massive data center build-out to power AI work for OpenAI and also counts companies such as ByteDance Ltd.’s TikTok and Meta Platforms Inc. as major cloud customers.- Shares of Gemini Space Station Inc. (GEMI) rallied after the company's application for a derivatives exchange was approved by the Commodity Futures Trading Commission Wednesday, in a move that will allow the company to join the fast-growing field of prediction markets. Gemini, co-founded by billionaire twin brothers Tyler and Cameron Winklevoss, will soon allow existing US customers to trade event contracts on its website and mobile app, the company said in a blog post. In a regulatory filing prior to its initial public offering, the firm included prediction markets on “economic, financial, political and sports forecasts” among the list of products it was interested in trading.- Shares of Eli Lilly & Co. (LLY) jumped in the premarket session after the company's next-generation obesity shot helped patients lose almost a quarter of their body weight, potentially making the experimental drug the most potent weight loss medicine yet. The late-stage study was designed to measure weight loss and pain associated with knee osteoarthritis, a condition closely linked to obesity. Patients on the highest dose of the drug — called retatrutide — lost more than 23% of their body weight in 68 weeks, Lilly said in a statement Thursday.See omnystudio.com/listener for privacy information.

  --------  

  3:30

  --------

  3:30
• Gemini Space Station Rises, Oracle Slumps, Eli Lilly Rises on Experimental Shot Cutting Weight

  On this episode of Stock Movers:- Gemini Space Station (GEMI) shares rise after the crypto exchange founded by the Winklevoss twins said it received a Designated Contract Market license from the Commodity Futures Trading Commission, allowing Gemini to offer prediction markets in the US.- Oracle (ORCL) Shares slump after the company forecast 3Q cloud sales growth below analyst estimates, raising concerns that supply constraints are preventing the cloud infrastructure provider from converting its large backlog to actual revenues. - Eli Lilly (LLY) shares rise after a next-generation obesity shot helped patients lose almost a quarter of their body weight, potentially making the experimental drug the most potent weight-loss medicine yet.See omnystudio.com/listener for privacy information.

  --------  

  3:13

  --------

  3:13

More Business podcasts

Trending Business podcasts

About Stock Movers

Stock Movers: Podcasts in Family